Literature DB >> 9372423

Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase.

R Gheorghiu1, M Yuan, L M Hall, D M Livermore.   

Abstract

Nineteen isolates of Klebsiella oxytoca were examined, representing 18 distinct strains. All were from a 1994 survey of resistance amongst klebsiellae in intensive care units in Europe, and all had reduced susceptibility, or were resistant, to cefuroxime, ceftriaxone and aztreonam, suggesting hyperproduction of the chromosomal K1 beta-lactamase. We sought to confirm this mechanism and to identify why the levels of resistance varied between isolates. Possible reasons for variation were differences in the quantity or subtype of the K1 enzyme or differences in this enzyme's interplay with permeability. Spectrophotometric assays showed that all 19 isolates had K1-like beta-lactamases and that these were present at > or = 15-fold higher levels than in beta-lactam-sensitive K. oxytoca isolates. Fourteen of the 19 isolates had the OXY-2 form of K1 enzyme, while the remaining five had the OXY-1 form, as determined by isoelectric focusing and PCR amplification. Most isolates with the OXY-2 enzyme were more resistant than those with the OXY-1 subtype, but this difference partly reflected enzyme quantity rather than subtype. More generally, and irrespective of enzyme subtype, levels of resistance were broadly related to beta-lactamase specific activity, and the degree of hyperproduction was a major determinant of the level of resistance. Nevertheless, other factors had a role too: several isolates had reduced susceptibility or were resistant to cefoxitin, which is not a substrate for K1 enzyme, and examination of outer membrane protein profiles revealed considerable strain-to-strain diversity in the molecular weight range typical of the major enterobacterial porins (40-48 kDa).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372423     DOI: 10.1093/jac/40.4.533

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  The extended-spectrum K1 beta-lactamase from Klebsiella oxytoca SC 10,436 is a member of the bla(OXY-2) family of chromosomal Klebsiella enzymes.

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Marie-Hélène Nicolas-Chanoine; Karen Bush; Fred W Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.

Authors:  C C Randegger; A Keller; M Irla; A Wada; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice.

Authors:  C Quentin; C Arpin; V Dubois; C André; I Lagrange; I Fischer; J-P Brochet; F Grobost; J Jullin; B Dutilh; G Larribet; P Noury
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

4.  Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.

Authors:  Oren Zimhony; Inna Chmelnitsky; Rita Bardenstein; Sorel Goland; Orly Hammer Muntz; Shiri Navon Venezia; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.

Authors:  Teresa Spanu; Maurizio Sanguinetti; Mario Tumbarello; Tiziana D'Inzeo; Barbara Fiori; Brunella Posteraro; Rosaria Santangelo; Roberto Cauda; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Teresa Spanu; Daniela Ciccaglione; Lucio Romano; Barbara Fiori; Giuseppe Nicoletti; Stefania Zanetti; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

7.  Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.

Authors:  Philip E Coudron
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca.

Authors:  Cindy Fevre; Mehdi Jbel; Virginie Passet; François-Xavier Weill; Patrick A D Grimont; Sylvain Brisse
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

9.  Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.

Authors:  D M Livermore; K J Oakton; M W Carter; M Warner
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

10.  Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Authors:  D Sirot; R Labia; P Pouedras; C Chanal-Claris; C Cerceau; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.